Johnson & Johnson News and Healthcare Innovation
235.76
4.3600
1.82 %
At close
06/15
USD
Daily range
234.71
237.86
237.86
Weekly range
230.41
241.60
241.60
JNJ stock edges higher with $1 billion Firefly Bio acquisition supporting oncology expansion: weekly forecast
Johnson & Johnson (JNJ) is trading at $238.90, finishing the week up $6.15 (2.57%). The asset remains above its weekly MA-20 ($235.47), MA-50 ($207.27), and MA-200 ...
Johnson & Johnson charts signal potential pharma breakout as sector momentum strengthens
Pharmaceutical shares are gaining leadership within healthcare as sector momentum improves against the broader market. That shift is supporting expectations that other large-cap drugmakers could ...
U.S. Department of State increases Ebola response funding for DRC and Uganda
As the Ebola outbreak response continues in the Democratic Republic of the Congo and Uganda, the U.S. Department of State is adding nearly $38 million to its direct funding effort. The increase ...
U.S. stocks extend midday sell-off as chipmakers, crypto names and recent listings slide
Defensive sectors are leading the market in Friday midday trading as investors pull back from technology and crypto-linked shares. The sharpest moves include fresh weakness in semiconductor ...
Johnson & Johnson stock ticks up as MACD and ADX show bullish signals: weekly analysis
Johnson & Johnson (JNJ) trades at $227.20 after rising $1.80 (0.78%) over the past week, positioning the price in the upper part of the weekly range. The asset sits ...
Johnson & Johnson shares dip amid rising selling pressure
Johnson & Johnson (JNJ) is currently trading at $225.78, down $5.18 or 2.24% for the day. The asset remains below its 20-day ($227.79) and 50-day ($232.77) moving averages, but stays well above ...
Johnson & Johnson stock holds above MA-50 with neutral Stochastic RSI in play: weekly review
Johnson & Johnson (JNJ) is currently trading at $230.62, sitting below the weekly MA-20 ($234.17) but well above both the MA-50 ($204.01) and MA-200 ($170.52). Over the ...
JNJ stock ticks up amid continued annual dividend increases: weekly report
Johnson & Johnson (JNJ) shares are trading at $227.69, which is below the weekly MA-20 ($232.56) but well above the MA-50 ($202.42) and MA-200 ($170.21). Over the last ...
Why is Johnson & Johnson stock up today?
Johnson & Johnson (JNJ) is currently trading at $229.57, up 2.19% on the day. The stock is positioned above its 20-day moving average, below its 50-day, and well above its 200-day, suggesting ...
U.S. House Energy and Commerce Committee schedules energy, health and environment actions this week
The House Committee on Energy and Commerce is set to convene one subcommittee hearing and two subcommittee markups in Washington this week. The agenda spans power transmission permitting, public ...
Johnson & Johnson stock targets $235 resistance with projected further upside: weekly review
Johnson & Johnson (JNJ) is currently trading at $228.12, which is below the weekly MA-20 ($231.35), but well above both the MA-50 ($200.89) and MA-200 ($169.92). Over ...
JNJ shares slide slightly with resistance looming at $231.70: weekly review
Johnson & Johnson (JNJ) is currently trading at $224.73, having declined by $2.56 (0.98%) over the last week and closing near the bottom of its recent weekly range. The ...
U.S. senators urge State Department to restore Gavi funding
A bipartisan group of U.S. senators is pressing the State Department to release already appropriated funds for Gavi, the global vaccine alliance. The lawmakers say $600 million approved for fiscal ...
Florida panel examines preventive care gaps in chronic disease fight
Florida healthcare providers are urging policymakers to expand access to preventive care as chronic disease continues to strain patients and public health finances. A House Ways and Means Health ...
JNJ shares hold above key moving averages supported by firm ADX reading: weekly report
Johnson & Johnson (JNJ) is currently trading at $225.43, posting a weekly decline of $2.15 or 1.00%. The asset sits just below its W1 MA-20 ($229.79), while holding well ...
Johnson & Johnson stock retreats, current volatility hints at potential rebound: weekly analysis
Johnson & Johnson (JNJ) is currently trading at $226.06, having declined by $8.24, or 3.53%, over the past week. The asset sits just below its weekly MA-20 ($229.15), ...
Citadel chief people officer exits as hedge fund talent competition intensifies
Competition for investment and recruiting talent remains a central operational issue for large hedge funds, particularly as firms expand specialist hiring teams. Citadel's chief people officer ...
JNJ shares edge higher as price holds above key MA-20 support: weekly outlook
Johnson & Johnson (JNJ) is currently trading at $240.15, rising $1.79 (0.75%) over the past week and maintaining a position well above its weekly MA-20 ($227.89), MA-50 ...
What triggered Johnson & Johnson shares' latest price surge
Johnson & Johnson (JNJ) is trading slightly below the MA-20 at $241.67, but remains above the MA-50 at $235.37 and well above the MA-200 at $195.40. The current price of $240.67 marks a daily gain ...
Johnson & Johnson stock price forecast for 2040: Pipeline depth and MedTech scale push toward $600
Johnson & Johnson (JNJ) is trading near $235.37, and the retracement has been gradual but persistent throughout most of March. What matters now is the post-spinoff earnings profile. TTM EPS is ...
Why is Johnson & Johnson stock down today?
Johnson & Johnson (JNJ) is trading at $238.23 after a daily drop of 2.04%. The price is below the SMA-20 of $244.18, but above the SMA-50 at $231.66 and well above the SMA-200 at ...
